DKCM
EW icon

Davidson Kempner Capital Management’s Edwards Lifesciences EW Stock Holding History

Davidson Kempner Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.7M Buy
317,500
+284,900
+874% +$23.9M 0.34% 74
2026
Q1 		$2.61M Buy
+32,600
New +$2.69M 0.03% 168
2017
Q1 		– Sell
-187,500
Closed -$5.86M – 170
2016
Q4 		$5.86M Buy
+187,500
New +$6.08M 0.12% 120

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davidson Kempner Capital Management's EW Position: Q2 2026 in Review

Davidson Kempner Capital Management increased its Edwards Lifesciences (EW) stake by 874% in Q2 2026, buying an estimated $23.9M and bringing the position to 317,500 shares worth $28.7M. The position accounts for 0.34% of the portfolio, ranked #74.

Davidson Kempner Capital Management first reported a position in EW in Q4 2016 and has held it in 3 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Davidson Kempner Capital Management held 317,500 shares of Edwards Lifesciences worth $28.7M as of Q2 2026.
  • Davidson Kempner Capital Management bought 284,900 Edwards Lifesciences shares in Q2 2026, an estimated $23.9M.
  • Edwards Lifesciences made up 0.34% of Davidson Kempner Capital Management's portfolio in Q2 2026, its #74 holding.
  • Davidson Kempner Capital Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 3 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.